Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
Open accessThe DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
More than 3000 antimicrobial peptides (AMPs) have been discovered, seven of which have been approved by the U.S. Food and Drug Administration (FDA). Now commercialized, these seven peptides have mostly been utilized for topical medications, though some have been injected into the body to treat severe bacterial infections. To understand the translational potential for AMPs, we analyzed FDA-approved drugs in the FDA drug database. We examined their physicochemical properties, secondary structures, and mechanisms of action, and compared them with the peptides in the AMP database. All FDA-approved AMPs were discovered in Gram-positive soil bacteria, and 98% of known AMPs also come from natural sources (skin secretions of frogs and toxins from different species). However, AMPs can have undesirable properties as drugs, including instability and toxicity. Thus, the design and construction of effective AMPs require an understanding of the mechanisms of known peptides and their effects on the human body. This review provides an overview to guide the development of AMPs that can potentially be used as antimicrobial drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cassini, A., Högberg, L. D., Plachouras, D., Quattrocchi, A., Hoxha, A., Simonsen, G. S., Colomb-Cotinat, M., Kretzschmar, M. E., Devleesschauwer, B., Cecchini, M., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30605-4 · Cited by 2,945
APD3: the antimicrobial peptide database as a tool for research and education
Wang, G., Li, X., & Wang, Z. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1278 · Cited by 2,388
DrugBank 4.0: shedding new light on drug metabolism
Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A. C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1068 · Cited by 1,993
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 1,927
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Lau, J. L., & Dunn, M. K. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.06.052 · Cited by 1,879 · cited 1×
“This suggests that controlling the selectivity, reducing the toxicity, and lowering unexpected side effects are essential to the design of AMPs as human medicines [38,49].”
BackgroundSynthetic therapeutic peptides: science and market
Vlieghe, P., Lisowski, V., Martinez, J., & Khrestchatisky, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.009 · Cited by 1,476
Poirel, L., Jayol, A., & Nordmann, P. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00064-16 · Cited by 1,447
The antimicrobial peptides and their potential clinical applications.
Lei, J., Sun, L., Huang, S., Zhu, C., Li, P., He, J., Mackey, V., Coy, D. H., & He, Q. (2019) · PubMed · Cited by 1,430
Challenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
The drug-resistant bacteria that pose the greatest health threats
Willyard, C. (2017) · Nature · doi:10.1038/nature.2017.21550 · Cited by 1,221
Barrel-Stave Model or Toroidal Model? A Case Study on Melittin Pores
Yang, L., Harroun, T. A., Weiss, T. M., Ding, L., & Huang, H. W. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75802-x · Cited by 1,114
Gold, H. S., & Moellering, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611073351907 · Cited by 1,070
A robotic platform for flow synthesis of organic compounds informed by AI planning
Coley, C. W., Thomas, D. A., Lummiss, J. A. M., Jaworski, J. N., Breen, C. P., Schultz, V., Hart, T., Fishman, J. S., Rogers, L., Gao, H., et al. (2019) · Science · doi:10.1126/science.aax1566 · Cited by 1,052
Matsuzaki, K. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00197-2 · Cited by 1,010
Insulin Degradation: Progress and Potential*
Duckworth, W. C., Bennett, R. G., & Hamel, F. G. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0349 · Cited by 871
Lam, S. J., O'Brien-Simpson, N. M., Pantarat, N., Sulistio, A., Wong, E. H. H., Chen, Y.-Y., Lenzo, J. C., Holden, J. A., Blencowe, A., Reynolds, E. C., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.162 · Cited by 821
Structure−Activity Relationships of Polymyxin Antibiotics
Velkov, T., Thompson, P. E., Nation, R. L., & Li, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900999h · Cited by 780
Collignon, P., Beggs, J. J., Walsh, T. R., Gandra, S., & Laxminarayan, R. (2018) · The Lancet Planetary Health · doi:10.1016/s2542-5196(18)30186-4 · Cited by 750
Cyclic peptide therapeutics: past, present and future
Zorzi, A., Deyle, K., & Heinis, C. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.02.006 · Cited by 737
Fox, R. O., & Richards, F. M. (1982) · Nature · doi:10.1038/300325a0 · Cited by 718
Control of cell selectivity of antimicrobial peptides
Matsuzaki, K. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.09.013 · Cited by 713
A Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective Drugs
Gordon, Y. J., Romanowski, E. G., & McDermott, A. M. (2005) · Current Eye Research · doi:10.1080/02713680590968637 · Cited by 697
A Comprehensive Review on Current Advances in Peptide Drug Development and Design
Lee, A. C.-L., Harris, J. L., Khanna, K. K., & Hong, J.-H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102383 · Cited by 686
Melittin: a Membrane-active Peptide with Diverse Functions
Raghuraman, H., & Chattopadhyay, A. (2007) · Bioscience Reports · doi:10.1007/s10540-006-9030-z · Cited by 651
Structure and Functions of Channel-Forming Peptides: Magainins, Cecropins, Melittin and Alamethicin
Bechinger, B. (1997) · Journal of Membrane Biology · doi:10.1007/s002329900201 · Cited by 602
Global dissemination of a multidrug resistant Escherichia coli clone
Petty, N. K., Ben Zakour, N. L., Stanton-Cook, M., Skippington, E., Totsika, M., Forde, B. M., Phan, M.-D., Gomes Moriel, D., Peters, K. M., Davies, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322678111 · Cited by 558
Epand, R. F., Savage, P. B., & Epand, R. M. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.05.023 · Cited by 537
Antimicrobial Peptides: Successes, Challenges and Unanswered Questions
Wimley, W. C., & Hristova, K. (2011) · The Journal of Membrane Biology · doi:10.1007/s00232-011-9343-0 · Cited by 495
THPdb: Database of FDA-approved peptide and protein therapeutics
Usmani, S. S., Bedi, G., Samuel, J. S., Singh, S., Kalra, S., Kumar, P., Ahuja, A. A., Sharma, M., Gautam, A., & Raghava, G. P. S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0181748 · Cited by 485
Lipopeptides from Bacillus and Paenibacillus spp.: A Gold Mine of Antibiotic Candidates
Cochrane, S. A., & Vederas, J. C. (2016) · Medicinal Research Reviews · doi:10.1002/med.21321 · Cited by 474
Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing
Lim, L. M., Ly, N., Anderson, D., Yang, J. C., Macander, L., Jarkowski, A., Forrest, A., Bulitta, J. B., & Tsuji, B. T. (2010) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.12.1279 · Cited by 444
Peptide Design Principles for Antimicrobial Applications
Torres, M. D. T., Sothiselvam, S., Lu, T. K., & de la Fuente-Nunez, C. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.12.015 · Cited by 438
Self-citationThe cost of antimicrobial resistance
Hofer, U. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0125-x · Cited by 427
Higgins, D. L., Chang, R., Debabov, D. V., Leung, J., Wu, T., Krause, K. M., Sandvik, E., Hubbard, J. M., Kaniga, K., Schmidt, D. E., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1127-1134.2005 · Cited by 425
Antimicrobial peptides and wound healing: biological and therapeutic considerations
Mangoni, M. L., McDermott, A. M., & Zasloff, M. (2016) · Experimental Dermatology · doi:10.1111/exd.12929 · Cited by 415
Cholesterol, the central lipid of mammalian cells
Maxfield, F. R., & van Meer, G. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.05.004 · Cited by 414
Human Insulin from Recombinant DNA Technology
Johnson, I. S. (1983) · Science · doi:10.1126/science.6337396 · Cited by 401
The gramicidin ion channel: A model membrane protein
Kelkar, D. A., & Chattopadhyay, A. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.05.011 · Cited by 380
Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests
Wehbe, R., Frangieh, J., Rima, M., El Obeid, D., Sabatier, J.-M., & Fajloun, Z. (2019) · Molecules · doi:10.3390/molecules24162997 · Cited by 372
Deformation free energy of bilayer membrane and its effect on gramicidin channel lifetime
Huang, H. W. (1986) · Biophysical Journal · doi:10.1016/s0006-3495(86)83550-0 · Cited by 364
Matsuzaki, K., Sugishita, K.-I., Harada, M., Fujii, N., & Miyajima, K. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00051-5 · Cited by 363
Carpenter, C. F., & Chambers, H. F. (2004) · Clinical Infectious Diseases · doi:10.1086/383472 · Cited by 358
New Lipoglycopeptides: A Comparative Review of Dalbavancin, Oritavancin and Telavancin
Zhanel, G. G., Calic, D., Schweizer, F., Zelenitsky, S., Adam, H., Lagacé-Wiens, P. R. S., Rubinstein, E., Gin, A. S., Hoban, D. J., & Karlowsky, J. A. (2010) · Drugs · doi:10.2165/11534440-000000000-00000 · Cited by 352
Hollmann, A., Martinez, M., Maturana, P., Semorile, L. C., & Maffia, P. C. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00204 · Cited by 334
Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide Analogs
Nguyen, L. T., Chau, J. K., Perry, N. A., de Boer, L., Zaat, S. A. J., & Vogel, H. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012684 · Cited by 333
Peptide design for antimicrobial and immunomodulatory applications
Haney, E. F., & Hancock, R. E. W. (2013) · Peptide Science · doi:10.1002/bip.22250 · Cited by 291
The roles of cathelicidin LL-37 in immune defences and novel clinical applications
Nijnik, A., & Hancock, R. E. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32831ac517 · Cited by 287
Porto, W. F., Irazazabal, L., Alves, E. S. F., Ribeiro, S. M., Matos, C. O., Pires, Á. S., Fensterseifer, I. C. M., Miranda, V. J., Haney, E. F., Humblot, V., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03746-3 · Cited by 284
Self-citationMechanistic Landscape of Membrane-Permeabilizing Peptides
Guha, S., Ghimire, J., Wu, E., & Wimley, W. C. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00520 · Cited by 280
Hilpert, K., Winkler, D. F., & Hancock, R. E. (2007) · Nature Protocols · doi:10.1038/nprot.2007.160 · Cited by 278
SDAP: database and computational tools for allergenic proteins
Ivanciuc, O. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg010 · Cited by 278
Cathelicidins: Immunomodulatory Antimicrobials
Van Harten, R. M., Van Woudenbergh, E., Van Dijk, A., & Haagsman, H. P. (2018) · Vaccines · doi:10.3390/vaccines6030063 · Cited by 258
‘Detergent-like’ permeabilization of anionic lipid vesicles by melittin
Ladokhin, A. S., & White, S. H. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00382-0 · Cited by 257
Wang, J., Yadav, V., Smart, A. L., Tajiri, S., & Basit, A. W. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500809f · Cited by 245
Hamamoto, K., Kida, Y., Zhang, Y., Shimizu, T., & Kuwano, K. (2002) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2002.tb02759.x · Cited by 242
Ambroggio, E. E., Separovic, F., Bowie, J. H., Fidelio, G. D., & Bagatolli, L. A. (2005) · Biophysical Journal · doi:10.1529/biophysj.105.066589 · Cited by 241
Antimicrobial Peptides and Nanotechnology, Recent Advances and Challenges
Biswaro, L. S., da Costa Sousa, M. G., Rezende, T. M. B., Dias, S. C., & Franco, O. L. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00855 · Cited by 227
Potential of immunomodulatory host defense peptides as novel anti-infectives
Easton, D. M., Nijnik, A., Mayer, M. L., & Hancock, R. E. W. (2009) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.07.004 · Cited by 215
Solution stability of linear vs. cyclic RGD peptides
Bogdanowich‐Knipp, S. J., Chakrabarti, S., Siahaan, T. J., Williams, T. D., & Dillman, R. K. (1999) · The Journal of Peptide Research · doi:10.1034/j.1399-3011.1999.00052.x · Cited by 206
Nijnik, A., & Hancock, R. E. W. (2009) · Emerging Health Threats Journal · doi:10.3134/ehtj.09.001 · Cited by 204
Recent Developments in Antimicrobial-Peptide-Conjugated Gold Nanoparticles
Rajchakit, U., & Sarojini, V. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00368 · Cited by 204
The antimicrobial peptide aurein 1.2 disrupts model membranes via the carpet mechanism
Fernandez, D. I., Le Brun, A. P., Whitwell, T. C., Sani, M.-A., James, M., & Separovic, F. (2012) · Physical Chemistry Chemical Physics · doi:10.1039/c2cp43099a · Cited by 200
Grönberg, A., Mahlapuu, M., Ståhle, M., Whately‐Smith, C., & Rollman, O. (2014) · Wound Repair and Regeneration · doi:10.1111/wrr.12211 · Cited by 191
Where are all the new antibiotics? The new antibiotic paradox
Conly, J., & Johnston, B. (2005) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2005/892058 · Cited by 186
Casciaro, B., Moros, M., Rivera-Fernández, S., Bellelli, A., de la Fuente, J. M., & Mangoni, M. L. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.09.041 · Cited by 180
Ab Initio Design of Potent Anti-MRSA Peptides Based on Database Filtering Technology
Mishra, B., & Wang, G. (2012) · Journal of the American Chemical Society · doi:10.1021/ja305644e · Cited by 175
Lipid Headgroup Discrimination by Antimicrobial Peptide LL-37: Insight into Mechanism of Action
Neville, F., Cahuzac, M., Konovalov, O., Ishitsuka, Y., Lee, K. Y. C., Kuzmenko, I., Kale, G. M., & Gidalevitz, D. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.067595 · Cited by 174
In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic
Eliopoulos, G. M., Willey, S., Reiszner, E., Spitzer, P. G., Caputo, G., & Moellering, R. C. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.4.532 · Cited by 173
Dissecting the Ribosomal Inhibition Mechanisms of Edeine and Pactamycin
Dinos, G., Wilson, D. N., Teraoka, Y., Szaflarski, W., Fucini, P., Kalpaxis, D., & Nierhaus, K. H. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00002-4 · Cited by 160
Torres, M. D. T., Pedron, C. N., Higashikuni, Y., Kramer, R. M., Cardoso, M. H., Oshiro, K. G. N., Franco, O. L., Silva Junior, P. I., Silva, F. D., Oliveira Junior, V. X., et al. (2018) · Communications Biology · doi:10.1038/s42003-018-0224-2 · Cited by 159
Self-citationIn-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic
Candiani, G., Abbondi, M., Borgonovi, M., Romanò, G., & Parenti, F. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.2.179 · Cited by 156
To protect peptide pharmaceuticals against peptidases
Rink, R., Arkema-Meter, A., Baudoin, I., Post, E., Kuipers, A., Nelemans, S. A., Akanbi, M. H. J., & Moll, G. N. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.02.010 · Cited by 153
Snake Venom Peptides: Tools of Biodiscovery
Munawar, A., Ali, S. A., Akrem, A., & Betzel, C. (2018) · Toxins · doi:10.3390/toxins10110474 · Cited by 153
Goluszko, P., & Nowicki, B. (2005) · Infection and Immunity · doi:10.1128/iai.73.12.7791-7796.2005 · Cited by 151
Wang, Y., Chen, C. H., Hu, D., Ulmschneider, M. B., & Ulmschneider, J. P. (2016) · Nature Communications · doi:10.1038/ncomms13535 · Cited by 127
Self-citationSimulation-Guided Rational de Novo Design of a Small Pore-Forming Antimicrobial Peptide
Chen, C. H., Starr, C. G., Troendle, E., Wiedman, G., Wimley, W. C., Ulmschneider, J. P., & Ulmschneider, M. B. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b11939 · Cited by 127
Self-citationTargeting Toll-like receptors with small molecule agents
Wang, X., Smith, C., & Yin, H. H. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60039d · Cited by 124
Dalbavancin: a novel antimicrobial
Chen, A. Y., Zervos, M., & Vazquez, J. A. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01318.x · Cited by 123
Modulation of toll-like receptor signaling by antimicrobial peptides
Lee, E. Y., Lee, M. W., & Wong, G. C. L. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.02.002 · Cited by 123
An artificial primitive mimic of the Gramicidin-A channel
Bãrboiu, M., Duc, Y. L., Gilles, A., Cazade, P., Michau, M., Legrand, Y., van der Lee, A., Coasne, B., Parvizi, P., Post, J. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms5142 · Cited by 119
Smith, J. R., Roberts, K. D., & Rybak, M. J. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0077-7 · Cited by 106
Worthington, R. J., Blackledge, M. S., & Melander, C. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.58 · Cited by 103
Bioinformatics Approaches to Classifying Allergens and Predicting Cross-Reactivity
Schein, C. H., Ivanciuc, O., & Braun, W. A. (2007) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.11.005 · Cited by 103
Spontaneous transmembrane helix insertion thermodynamically mimics translocon-guided insertion
Ulmschneider, M. B., Ulmschneider, J. P., Schiller, N., Wallace, B. A., von Heijne, G., & White, S. H. (2014) · Nature Communications · doi:10.1038/ncomms5863 · Cited by 101
Lee, T.-H., Hofferek, V., Separovic, F., Reid, G. E., & Aguilar, M. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.05.025 · Cited by 100
Alghoribi, M. F., Gibreel, T. M., Farnham, G., Johani, S. M. A., Balkhy, H. H., & Upton, M. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv188 · Cited by 92
Klein, T., Henn, C., de Jong, J. C., Zimmer, C., Kirsch, B., Maurer, C. K., Pistorius, D., Müller, R., Steinbach, A., & Hartmann, R. W. (2012) · ACS Chemical Biology · doi:10.1021/cb300208g · Cited by 86
The Structure of a Melittin-Stabilized Pore
Leveritt, J. M., Pino‐Ángeles, A., & Lazaridis, T. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2015.04.006 · Cited by 84
Takahashi, T., Kulkarni, N. N., Lee, E. Y., Zhang, L., Wong, G. C. L., & Gallo, R. L. (2018) · Scientific Reports · doi:10.1038/s41598-018-22409-3 · Cited by 84
Pacor, S. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf141 · Cited by 80
In-solution enrichment identifies peptide inhibitors of protein–protein interactions
Touti, F., Gates, Z. P., Bandyopadhyay, A., Lautrette, G., & Pentelute, B. L. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0245-2 · Cited by 80
Daptomycin – a novel antibiotic against Gram-positive pathogens
LaPlante, K. L., & Rybak, M. J. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.11.2321 · Cited by 72
Simulations of Membrane-Disrupting Peptides II: AMP Piscidin 1 Favors Surface Defects over Pores
Perrin, B. S., Fu, R., Cotten, M. L., & Pastor, R. W. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.08.015 · Cited by 71
Stability of peptide drugs in the colon
Wang, J., Yadav, V., Smart, A. L., Tajiri, S., & Basit, A. W. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.06.018 · Cited by 67
Peptide antibiotics of the tuberactinomycin family as inhibitors of group I intron RNA splicing
Wank, H., Rogers, J., DAVIES, J. E., & Schroeder, R. (1994) · Journal of Molecular Biology · doi:10.1016/0022-2836(94)90007-8 · Cited by 63
Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections
Zhanel, G. G., Trapp, S., Gin, A. S., DeCorby, M. R., Lagacé-Wiens, P. R. S., Rubinstein, E., Hoban, D. J., & Karlowsky, J. A. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.1.67 · Cited by 63
Screening and Optimizing Antimicrobial Peptides by Using SPOT-Synthesis
Lopez-Perez, P. M., Grimsey, E. M., Bourne, L., Mikut, R., & Hilpert, K. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00025 · Cited by 59
Xenoprotein engineering via synthetic libraries
Gates, Z. P., Vinogradov, A. A., Quartararo, A. J., Bandyopadhyay, A., Choo, Z.-N., Evans, E. D., Halloran, K. H., Mijalis, A. J., Mong, S. K., Simon, M. D., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722633115 · Cited by 59
Transmembrane helix assembly and the role of salt bridges
Walther, T. H., & Ulrich, A. S. (2014) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2014.05.003 · Cited by 56
Brunetti, J., Roscia, G., Lampronti, I., Gambari, R., Quercini, L., Falciani, C., Bracci, L., & Pini, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.750257 · Cited by 54
Daptomycin–Phosphatidylglycerol Domains in Lipid Membranes
Kreutzberger, M. A. B., Pokorny, A., & Almeida, P. F. F. (2017) · Langmuir · doi:10.1021/acs.langmuir.7b01841 · Cited by 53
Effects of Peptide Charge, Orientation, and Concentration on Melittin Transmembrane Pores
Pino‐Ángeles, A., & Lazaridis, T. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.05.006 · Cited by 52
Membrane permeabilization of colistin toward pan-drug resistant Gram-negative isolates
Mohamed, Y. F., Abou-Shleib, H. M., Khalil, A. M., Guink, N. E., & El-Nakeeb, M. A. (2016) · Brazilian Journal of Microbiology · doi:10.1016/j.bjm.2016.01.007 · Cited by 50
Proteomic Analysis of Skin Defensive Factors of Tree Frog Hyla simplex
Wu, J., Liu, H., Yang, H., Yu, H., You, D., Ma, Y., Ye, H., & Lai, R. (2011) · Journal of Proteome Research · doi:10.1021/pr200393t · Cited by 49
Native Mass Spectrometry of Antimicrobial Peptides in Lipid Nanodiscs Elucidates Complex Assembly
Walker, L. R., Marzluff, E. M., Townsend, J. A., Resager, W., & Marty, M. T. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b02261 · Cited by 49
Daptomycin Pore Formation and Stoichiometry Depend on Membrane Potential of Target Membrane
Seydlová, G., Sokol, A., Lišková, P., Konopásek, I., & Fišer, R. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01589-18 · Cited by 48
The Antibiotics Dityromycin and GE82832 Bind Protein S12 and Block EF-G-Catalyzed Translocation
Bulkley, D. P., Brandi, L., Polikanov, Y. S., Fabbretti, A., O’Connor, M., Gualerzi, C. O., & Steitz, T. A. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.024 · Cited by 45
Antibacterial Peptides in Dermatology–Strategies for Evaluation of Allergic Potential
Deptuła, M., Wardowska, A., Dzierżyńska, M., Rodziewicz‐Motowidło, S., & Pikuła, M. (2018) · Molecules · doi:10.3390/molecules23020414 · Cited by 41
Comparison of the Effects of Daptomycin on Bacterial and Model Membranes
Lee, M.-T., Yang, P.-Y., Charron, N. E., Hsieh, M.-H., Chang, Y.-Y., & Huang, H. W. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00818 · Cited by 39
Henderson, J. M., Iyengar, N. S., Lam, K. L. H., Maldonado, E., Suwatthee, T., Roy, I., Waring, A. J., & Lee, K. Y. C. (2019) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.04.011 · Cited by 32
Szer, W., & Kurylo-Borowska, Z. (1972) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(72)90310-3 · Cited by 26
Rational design of new cyclic analogues of the antimicrobial lipopeptide tridecaptin A 1
Ballantine, R. D., Li, Y., Qian, P., & Cochrane, S. A. (2018) · Chemical Communications · doi:10.1039/c8cc05790g · Cited by 22
AllerML: Markup language for allergens
Ivanciuc, O., Gendel, S. M., Power, T. D., Schein, C. H., & Braun, W. A. (2011) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2011.03.006 · Cited by 13
In Vitro Evaluation of the Allergic Potential of Antibacterial Peptides: Camel and Citropin
Pikuła, M., Zieliński, M., Specjalski, K., Barańska‐Rybak, W., Dawgul, M. A., Langa, P., Jassem, E., Kamysz, W., & Trzonkowski, P. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12688 · Cited by 9
Cited by
Antimicrobial peptides for combating drug-resistant bacterial infections
Xuan, J., Feng, W., Wang, J., Wang, R., Zhang, B., Bo, L., Chen, Z.-S., Yang, H., & Sun, L. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100954 · Cited by 665
Biomaterial-based antimicrobial therapies for the treatment of bacterial infections
Kalelkar, P. P., Riddick, M., & García, A. J. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00362-4 · Cited by 548
Gan, B. H., Gaynord, J., Rowe, S. M., Deingruber, T., & Spring, D. R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00729c · Cited by 511
Antimicrobial peptides as therapeutic agents: opportunities and challenges
Mahlapuu, M., Björn, C., & Ekblom, J. (2020) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2020.1796576 · Cited by 484
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Zheng, W., Hu, Y., & Shi, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02107-5 · Cited by 449
Metadata
- Authors
- Chen, C. H., & Lu, T. K.
- Venue
- Antibiotics
- Publisher
- MDPI AG
- Published
- 2020-01-13
- Volume
- 9
- Issue
- 1
- Pages
- 24
- ISSN
- 2079-6382 (ISSN-L)
- OpenAlex
- W2999569426
- Cited by
- 598
- References
- 114
- FWCI
- 47.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.